PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.\', \'Cambridge Liver Unit, Addenbrooke\'s Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.\', \'Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Department of Hepatology and Liver Transplantation, Asian Institute of Gastroenterology Hospitals, Gachibowli, Hyderabad, India.\', \'Department of Gastroenterology and Hepatology, University of Health Sciences Istanbul Umraniye Training and Research Hospital, Istanbul, Turkey.\', \'Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.\', \'Department of Medicine and Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.\', \'Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, University Hospital of Larissa, Larissa, Greece.\', \'Liver Transplant Unit, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.\', \'Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.\', \'Oxford Liver Unit, Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/hep4.1853
?:doi
?:hasPublicationType
?:journal
  • Hepatology communications
is ?:pmid of
?:pmid
?:pmid
  • 34708575
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all